BACKGROUND: Clear cell (hemangioblastoma-like) stromal tumor of the lung (CCSTL) is a rare pulmonary neoplasm. Recently, 9 cases of CCSTL harboring the YAP1-TFE3 gene fusion have been described, and it has been suggested that this aberration could be a characteristic feature of this tumor. CASE PRESENTATION: We here report another case of CCSTL in a 57-year-old male, which presented as a solitary lung nodule 45 mm in the greatest dimension. Microscopically, the tumor consisted of epithelioid to spindled cells with mild-to-moderate nuclear atypia, finely granular or vesicular chromatin, and small nucleoli. Nuclear indentations were a common finding. There were up to 3 mitoses per 10 HPF. The cytoplasm was slightly eosinophilic or clear. Scattered non-tumor large multinucleated cells were present. Immunohistochemically, the tumor cells showed diffuse positivity for TFE3, CD10, vimentin, and IFITM1. Other markers examined were negative, and the expression of lineage-specific markers was not found. NGS analysis revealed a fusion transcript of the YAP1 and TFE3 genes, and a pathogenic variant of the MUTYH gene. CONCLUSION: Our finding supports the recent data suggesting that CCSTL represents a distinct entity characterized by the recurrent YAP1-TFE3 fusion.

Department of Abdominal Thoracic Surgery and Traumatology 1st Faculty of Medicine Charles University and General University Hospital Prague U Nemocnice 2 128 00 Prague 2 Czech Republic

Department of Pathology 1st Faculty of Medicine Charles University and General University Hospital Prague Studničkova 2 128 00 Prague 2 Czech Republic

Department of Pathology and Molecular Medicine 3rd Faculty of Medicine Charles University Thomayer Hospital Prague Czech Republic

Department of Pathology Charles University 3rd Faculty of Medicine University Hospital Kralovske Vinohrady Prague Czech Republic

Zobrazit více v PubMed

Falconieri G, Mirra M, Michal M, Suster S. Hemangioblastoma-like clear cell stromal tumor of the lung. Adv Anat Pathol. 2013;20(2):130–135. doi: 10.1097/PAP.0b013e318286245d. PubMed DOI

Agaimy A, Stoehr R, Michal M, Christopoulos P, Winter H, Zhang L, et al. Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung. Am J Surg Pathol. 2021;45(11):1541–1549. doi: 10.1097/PAS.0000000000001719. PubMed DOI PMC

Lindholm KE, Moran CA. Hemangioblastoma-like Clear Cell Stromal Tumor of the Lung: A Clinicopathologic and Immunohistochemical Study of 5 Cases. Am J Surg Pathol. 2020;44(6):771–775. doi: 10.1097/PAS.0000000000001429. PubMed DOI

Dermawan JK, Azzato EM, McKenney JK, Liegl-Atzwanger B, Rubin BP. YAP1-TFE3 gene fusion variant in clear cell stromal tumour of lung: report of two cases in support of a distinct entity. Histopathology. 2021;79(6):940–946. doi: 10.1111/his.14437. PubMed DOI

Zhang X, Huang B, Jiang H, Wei H. Case Report: Hemangioblastoma- Like Clear Cell Stromal Tumor of the Left Lower Lung. Front Med (Lausanne) 2022;9:836012. doi: 10.3389/fmed.2022.836012. PubMed DOI PMC

Dehner CA, Sadegh D, Boulos F, Messias N, Wang WL, Demicco EG, et al. Clear cell stromal tumour of the lung with YAP1::TFE3 fusion: four cases including a case with highly aggressive clinical course. Histopathology. 2022;81(2):239–245. doi: 10.1111/his.14706. PubMed DOI

Ticha I, Hojny J, Michalkova R, Kodet O, Krkavcova E, Hajkova N, et al. A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants. Sci Rep. 2019;9(1):17050. doi: 10.1038/s41598-019-53636-x. PubMed DOI PMC

Dahm HH. Non-Small Cell Carcinoma of the Lung With Osteoclast-Like Giant Cells. Int J Surg Pathol. 2017;25(3):258–261. doi: 10.1177/1066896916679519. PubMed DOI PMC

Liang R, Li X, Zhu X. Deciphering the Roles of IFITM1 in Tumors. Mol Diagn Ther. 2020;24(4):433–441. doi: 10.1007/s40291-020-00469-4. PubMed DOI

Dundr P, Gregova M, Hojny J, Krkavcova E, Michalkova R, Nemejcova K, et al. Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases. Virchows Arch. 2022;480(2):281–291. doi: 10.1007/s00428-021-03217-z. PubMed DOI

Sun H, Fukuda S, Hirata T, Arakawa T, Neriishi K, et al. IFITM1 is a novel, highly sensitive marker for endometriotic stromal cells in ovarian and extragenital endometriosis. Reprod Sci. 2020;27(8):1595–1601. doi: 10.1007/s43032-020-00189-4. PubMed DOI

Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol. 2010;34(10):1395–1406. doi: 10.1097/PAS.0b013e3181f17ac0. PubMed DOI

Chang IW, Huang HY, Sung MT. Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts. Am J Surg Pathol. 2009;33(12):1894–1901. doi: 10.1097/PAS.0b013e3181ba7a5f. PubMed DOI

Antonescu CR, Le Loarer F, Mosquera JM, Sboner A, Zhang L, Chen CL, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer. 2013;52(8):775–784. doi: 10.1002/gcc.22073. PubMed DOI PMC

Puls F, Niblett A, Clarke J, Kindblom LG, McCulloch T. YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant. Virchows Arch. 2015;466(4):473–478. doi: 10.1007/s00428-015-1730-y. PubMed DOI

Kuo FY, Huang HY, Chen CL, Eng HL, Huang CC. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study. APMIS. 2017;125(9):849–853. doi: 10.1111/apm.12716. PubMed DOI

Zhang HZ, Dong L, Wang SY, Yang XQ. TFE3 rearranged epithelioid hemangioendothelioma of bone: A clinicopathological, immunohistochemical and molecular study of two cases. Ann Diagn Pathol. 2020;46:151487. doi: 10.1016/j.anndiagpath.2020.151487. PubMed DOI

Patton A, Bridge JA, Liebner D, Chung C, Iwenofu OH. A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity! Genes Chromosomes Cancer. 2022;61(4):194–199. doi: 10.1002/gcc.23018. PubMed DOI